GLP-1 weight loss medications like Ozempic and Wegovy have become blockbuster drugs, but the need for weekly injections has limited their use. This may soon change, as several oral versions are nearing FDA approval, CNN reported Sept. 17.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
